Please assess the completion status of the following clinical trial:

Trial Title: Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* adequate WBC~* adequate liver and kidney function~* no immunodeficiency~* ECOG \< 2~Exclusion Criteria:~* advanced liver cirrhosis~* severe cardiopulmonary diseases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).